Fundz

OnKure Announces the Appointment of Samuel Agresta, M.D., as Chief Medical Officer

PRIVATEFeb 15, 2024

Position

Chief Medical Officer

Company

OnKure Therapeutics

Samuel Agresta
sagresta@onkure.com
BoulderBiotechnologyHealthcareTherapeuticsPharmaceuticalBiopharma

Description

OnKure, Inc. announces the appointment of Samuel Agresta, M.D., M.P.H. as Chief Medical Officer.

Who to call at OnKure Therapeutics, and when

A new leader at OnKure Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day OnKure Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OnKure Therapeutics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OnKure Therapeutics

Location

6707 WINCHESTER CIRCLE

Boulder, Colorado, United States

About

OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of best-in-class precision medicines that target biologically significant and well-validated pharmacological pathways, with a focus on oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OnKure Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Samuel
Likely contact at this company
••••••••@••••••••

See Samuel's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for OnKure Therapeutics's next move

Learn about Strategic plan

OnKure Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.